Teratogenic and developmental effects of lithium

Current Pharmaceutical Design

Volumn 12, Issue 12, 2006, Pages 1531-1541

  Giles, James J ^a,b   Bannigan, John G ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Angiogenesis; Ebstein anomaly; Lithium; Myo inositol; Phosphatidylinositol cycle; Vasculogenesis; Wnt GSK 3 pathway

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; INOSITOL; LITHIUM; PHOSPHATIDYLINOSITOL; WNT PROTEIN; TERATOGENIC AGENT;

ANGIOGENESIS; ARTICLE; BIPOLAR DISORDER; BONE DEFECT; BONE MALFORMATION; CLEFT PALATE; CONGENITAL BLOOD VESSEL MALFORMATION; CONGENITAL HEART MALFORMATION; CRANIOFACIAL MALFORMATION; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG MEGADOSE; DRUG PENETRATION; EBSTEIN ANOMALY; EMBRYO; ENZYME INHIBITION; EXENCEPHALY; EYE MALFORMATION; FETUS DEATH; HIGH BIRTH WEIGHT; HUMAN; INHIBITION KINETICS; INVERTEBRATE; MEDICAL RESEARCH; MOUSE; NONHUMAN; PREGNANCY OUTCOME; PRIORITY JOURNAL; RAT; SPINAL CORD MALFORMATION; TERATOGENICITY; VERTEBRATE; ANIMAL; CONGENITAL MALFORMATION; DRUG EFFECT; METABOLISM; REPRODUCTION; REVIEW;

ABNORMALITIES; ANIMALS; HUMANS; LITHIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHATIDYLINOSITOLS; REPRODUCTION; TERATOGENS;

EID: 33745083138     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206776389804     Document Type: Article

References (86)

1. Lipowitz A. Veruche und resultate uber die loslichkeit der harnsaure. Ann Chem Pharmacol 1841; 38: 348-55.
2. Garrod AB. In: Gout and rheumatic gout. (Ed. A.B. Garrod) London: Walton and Maberly 1859.
3. Corcoran AC, Taylor RD, Page I. Lithium poisoning from the use of salt substitutes. JAMA 1949; 139: 685-88.
4. Greenfield I, Zuger M, Bleak RM, Bakal S. Lithium chloride intoxication. NY State J Med 1950; 50: 459-60.
5. Hanlon LW, Romaine M, Gilroy FJ, Dietrich JE. Lithium chloride as a substitute for sodium chloride in the diet. JAMA 1949; 139; 688-92.
6. Cade JFJ. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 36; 349-52.
7. Noack CH, Trautner EM. The lithium treatment of maniacal psychosis. Med J Aust 1951; 38: 219-22.
8. Carrere J, Pochard A. Le citrate de lithium dans le traitment de syndromes d excitation psychomotrice. Ann Med Psychol 1954; 112: 566-72.
9. Glesinger B, Evaluation of lithium treatment of psychotic excitement. Med J Aust 1954, 41: 277-83.
10. Schou M, Juel-Nielsen N, Stromgren E, Voldby H. The treatment of manic psychosis by the administration of lithium salts. J Neurol Psychiatry 1954; 17: 250-60.
11. Hartigan GP. The use of lithium salts in affective disorders. Br J Psychiatry 1963; 109: 810-14.
12. Baastrup PC. The use of lithium in manic-depressive psychosis. Compr Psychiatry 1964; 5: 396-408.
13. Gershon S. The possible thymoleptic effect of the lithium ion. Am J Psychiatry 1968; 124: 1452-456.
14. Price LH, Heninger GR. Lithium in the treatment of mood disorders. New Engl J Med 1994; 331: 591-599.
15. Herbst C. Experimentelle untersuchunger über den einfluss der veranderten chemischen zusammensetzung des umgebenden mediums auf die entwicklangder tiere 1. Zeitschrift F. Wiss Zool Bd 1892; 55: S446.
16. Runnström J. An analysis of the action of lithium on sea-urchin development Biol Bull 1935; 68: 378.
17. Burt AS. Neuralation in mechanically and chemically inhibited Amblystoma. Biol Bull 1943; 85: 103-115.
18. Robins LN, Heizer VL, Weissman, MM. Lifetime prevalence of specific psychiatric disorders. Arch Gen Psychiatry 1984; 41: 949-958.
19. Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ. Risk of recurrence of bipolar disorder in pregnant and non-pregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000; 157: 179-84.
20. Moore JA, IEHR Scientific Committee. An assessment of lithium using the IEHR evaluative process for assessing human developmental and reproductive toxicity of agents. Reprod Toxicol 1995; 9: 175-210.
21. Poust RI. Lithium: kinetics and tissue distribution. In: Depression and Mania- modern lithium therapy. (ed. F.N.Johnson), Oxford, Washington DC: Irl Press 1987; 73-5.
22. Amdisen A, Sjogren J. Lithium absorption from sustained release tablets (Duretter). Acta Pharm Suec 1968; 5: 465-72.
23. Schou M, Amdisen A. Lithium and the Placenta. Am J Obstet Gynecol 1975; 122: 541.
24. Sykes PA, Quarrie J, Alexander FW. Lithium carbonate and breast feeding. BMJ 1976; 2: 1299.
25. Rane A, Tomson G, Bjarke B. Effects of maternal lithium therapy in a newborn infant. J Pediatr 1978; 93: 296-97.
26. Smithberg M, Dixit P. Teratogenic effects of lithium in mice. Teratology 1982; 26: 239-46.
27. Giles JJ, Bannigan JG. The effects of lithium on neurulation stage mouse embryos. Arch Toxicol 1997; 71: 519-28.
28. Talso PJ, Clarke RW. Excretion and distribution of lithium in the dog. Am J Physiol 1951, 166: 202-8.
29. Morrison JM, Pritchard HD, Braude MC, D'Aguanno W. Plasma and brain lithium levels after lithium chloride and lithium carbonate administration by different routes in rats. Proc Soc Exp Biol Med 1971; 137: 889-92.
30. Schou M, Goldfield Md, Weinstein MR, Villeneuve A. Lithium and pregnancy-1, report from the register of lithium babies. BMJ 1973; 2: 135-136.
31. Weinstein MR, Goldfield MD. Cardiovascular malformations with lithium use during pregnancy. Am J Psychiatry 1975, 132: 529-531.
32. Weinstein MR. The international register of lithium babies. Drug Inf J 1976; 10: 94-100.
33. Kallen B, Tandberg A. Lithium and pregnancy: a cohort study on manic-depressive women. Acta Psychiatr Scand 1983; 68: 134-39.
34. Kallen B. Comments on teratogen update: Lithium. Teratology 1988; 38: 597.
35. Zalzstein E, Gideon K, Einerson T, Freedom RM. A case-control study on the association between first trimester exposure to lithium and Ebsteins anomaly. Am J Cardiol 1990;65: 817-818.
36. Correa-Villasenor A, Ferencz C, Neill CA, Wilson PD, Boughman JA. Ebstein's malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington Infunt Study Group. Teratology 1994; 50: 137-47.
37. Jacobson SJ, Jones K, Johnson K, Ceolin L, Kaur P, Sahn D, et al. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 1992; 339: 530-533.
38. Long WA, Willis PW 4th. anomaly: evaluation with cross-sectional echocardiography. Am J Perinatol 1984; 1: 182-4.
39. Park JM, Sridaromont S, Ledbetter EO, Terry WM. Valve associated with prenatal exposure to lithium carbonate. Am J Dis Child 1980; 134: 703-4.
40. O'Donovan P, O'Herlihy C, Roystan D. Hydrops fetalis and congenital mitral valve stenosis associated with maternal lithium treatment. J Obstet Gynaecol 1984; 5: 101-5.
41. Pinelli JM, Symington AJ, Cunningham KA, Paes BA. Perinatal implications of maternal lithium use. Am J Obstet Gynecol 2002; 187: 245-9.
42. Cohen LS, Friedman JM, Jefferson, JW, Marshall-Johnson E, Weiner ML. A reevaluation of risk of in utero exposure to lithium. JAMA 1994; 271: 146-50.
43. Austin MV, Mitchell PB. Psychotropic medications in pregnant women: treatment dilemmas. Med J Aust 1998; 169: 428-31.
44. Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Pschiatry 2004; 161: 608-20.
45. Bäckström S. Morphogenetic effects of lithium an the embryonic development of Xenopus. Arkiv För Zoolgi 1954; 6: 527-36.
46. Stanisstreet M. Comparison of the effects of lithium, betaphenylethylamine and thyrosine on Xenopus embryos. Experientia 1974; 30: 1081-82.
47. Kao KR, Mosui Y, Elinson RP. Lithium induced respecification of pattern in Xenopus laevis embryos. Nature 1986; 322: 371-73.
48. Breckenridge LJ, Warren RL, Warner A. Lithium inhibits morphogenesis of the nervous system but not neuronal differentiation in Xenopus Laevis. Development 1987; 99: 353-70.
49. Rogers KT. Experimental production of perfect cyclopia in the chick by means of LiCl with a survey of the literature on cyclopia produced experimentally by various means. Develop Biol 1963; 8: 129-150.
50. Duvauchelle R. Role of the lithium ion in the development of blastodiscs of chick embryos cultured in vitro. Biologica (Santiago) 1966; 39: 56-67.
51. Puzanova L, Doskocil M. Teratogenic effects of lithhium salts on young chick embryos. Folia Morphol 1979; 27: 26-30.
52. Trautner EM, Pennycuik PR, Morris RJH, Greshon S, Shankly KR. The effects of prolonged subtoxic lithium injestion on pregnancy in rats. Aust J Exp Biol Med Sci 1958, 36: 305-22.
53. Johansen KT, Ulrich K. Preliminary studies of the possible teratogenic effect of lithium. Acta Psychiatr Scand 1969; 207: 91-5.
54. Gralla EJ, Mc Ilhenny HM. Studies in pregnant rats, rabbits and monkeys with lithium carbonate. Toxicol Appl Pharmacol 1972; 21: 428-33.
55. Wright TL, Hoffman LH, Davies J. Teratogenic effects of lithium in rats. Teratology 1971; 4: 151-56.
56. Johansen KT. Lithium teratogenicity. Lancet 1971; 1: 1026-27.
57. Marathe MR, Thomas G. Embryotoxicity and teratogenicity of lithium carbonate in wistar rat. Toxicol Lett 1986; 34: 115-20.
58. Hoberman AM, Deprospo JR, Lochry EA, Christian MS. Developmental toxicity study of orally administered lithium hypochlorite in rats. J Am Coll Toxicol 1990, 9: 367-79.
59. Szabo KT, Teratogenic effect of lithium carbonate in the foetal mouse. Nature 1970; 225: 73-5.
60. Loevy HT, Lithium ion in cleft palate teratogenesis in CD-1 mice. Proc Royal Soc Exp Biol Med 1973; 144: 644-46.
61. Smithberg M, Dixit PK. Teratogenic effects of lithium in mice. Teratology 1982; 26: 239-46.
62. Jurand A. Treatogenic activity of lithium carbonate: an experimental update. Teratology 1988; 38: 101-11.
63. Hansen DK, Walker RC, Grafton TF. Effect of lithium carbonate on mouse and rat embryos in vitro. Teratology 1990; 41: 155-60.
64. Tesh JM. The application of whole embryo culture to new product development. Toxicol in vitro 1988, 2: 189-194.
65. Klug S, Collins M, Nagao T, Merker HJ, Neubert D. Effect of lithium on rat embryos in culture: growth, development, compartmental distribution and lack of a protective effect of inositol. Arch Toxicol 1992; 66: 719-728.
66. Berridge MJ, Downes CP, Hanley MR. Neural and developmental actions of lithium: A unifying hypothesis. Cell 1989; 59: 411-419.
67. Hallcher LM, Sherman WR. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem 1980; 225: 10896-901.
68. Busa WB, Gimlich RL. Lithium-induced teratogenesis in frog embryos prevented by a polyphosphoinositide cycle intermediate or a diacylglycerol analog. Develop Biol 1989; 132: 315-24.
69. Giudice G, Grasso G, Sconzo G, Cascino D, Scardina G, Ferraro MG. Myo-inositol counteracts the vegetalising effect of lithium on P. Lividus embryos. Cell Biol Int Rep 1992; 16: 47-52.
70. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996; 93: 8455-9.
71. Warkany J. Teratogen update: Lithium. Teratology 1988; 38: 593-96.
72. Pinter E, Reece A, Leranth CZ, Garcia-Segura M, Hobbins JC, Mahony MJ, Naftolin F. Arachidonic acid prevents hyperglycemia-associated yolk sac damage and embryopathy. Am J Obstet Gynecol. 1986; 155: 691-702.
73. Baker L, Piddington R, Goldman A, Egler J, Moehring J. Myoinositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos. Diabetologia 1990; 33: 593-596.
74. Wright PS, Cross-Doersen D, Miller JA, Jones WD, Bitonti AJ. Inhibition of angiogenesis in vitro and in ovo with an inhibitor of cellular protein kinases (MDL 27032). J Cell Physiol 1992; 152: 448-57.
75. Giles JJ, Bannigan JG. The effects of lithium on vascular development in the chick area vasculosa. J Anat 1999; 194: 197-205.
76. Gurvich N, Klein PS. Lithium and valproic acid: parallels and contrasts in diverse signaling contexts. Pharmacol Ther 2002; 96: 45-66.
77. Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 1997; 185: 82-91.
78. Emily-Fenouil F, Ghiglione C, Lhomond G, Lepage T, Gache C. GSK3beta/ shaggy mediates patterning along the animal-vegetal axis of the sea urchin embryo. Development 1998; 125: 2489-98.
79. Pillai MC, Vines CA, Wikramanayake AH, Cherr GN. Polycyclic aromatic hydrocarbons disrupt axial development in sea urchin embryos through a beta-catenin dependent pathway. Toxicology 2003; 186: 93-108.
80. Roeser T, Stein S, Kessel M. Nuclear beta-catenin and the development of bilateral symmetry in normal and LiCl-exposed chick embryos. Development 1999; 126: 2955-65.
81. van de Water S, van de Wetering M, Joore J, Esseling J, Bink R, Clevers H, et al. Ectopic Wnt signal determines the eyeless pheno-type of zebrafish masterblind mutant. Development 2001; 128: 3877-88.
82. Kume S, Muto A, Inoue T, Suga K, Okano H, Mikoshiba K Role of inositol 1,4,5-trisphosphate receptor in ventral signaling in Xenopus embryos. Science 1997; 12; 278(5345): 1940-3.
83. Wang HY, Malbon CC. Wnt signaling, Ca2+, and cyclic GMP: visualizing frizzled functions. Science 2003, 6; 300(5625): 1529-30.
84. Brauer PR, Tiernay BJ. Consequences of elevated homocysteine during embryonic development and possible modes of action. Curr Pharm Des 2004; 10(22): 2719-32.
85. Tiboni GM, Clemontini E. Teratological consequences of nitric oxide synthesis inhibition. Curr Pharm Des 2004; 10(22) 2759-67.
86. Yasui K, Kobayashi N, Yamanuki T, A K. Tholidomide as an immunotherapeutic agent: teh effects on inflamation. Curr Pharm Des 2005; 11(3): 395-401.